脑区域组织氧饱和度指导早产儿出生后即时过渡期氧输送(COSGOD III):多中心随机3期临床试验
该多中心随机3期试验在11个三级新生儿重症监护病房筛查1121名孕周<32周的孕妇,分析607名早产儿,比较常规监护联合脑组织氧饱和度监测与指南干预是否提高无脑损伤存活率。结果显示两组脑组织氧饱和度相似,无脑损伤存活率联合组82.9% vs 对照组78.5%(RR 1.06,95%CI 0.98-1.14),差异未达统计学显著。
要点
- 脑组织氧饱和度监测联合指南干预未显著提高早产儿无脑损伤存活率(RR 1.06,95%CI 0.98-1.14)。
- 联合组无脑损伤存活率82.9% vs 对照组78.5%,绝对增加4.3%但未达统计学显著。
- 两组脑组织氧饱和度相似,死亡率联合组4.0% vs 对照组5.3%(RR 0.75,95%CI 0.33-1.70)。
核心结论
- 早产儿(孕周<32周)出生后即时过渡和复苏期间,脑组织氧饱和度监测联合特定干预与单独标准护理相比,未显著提高无脑损伤存活率。
- 无脑损伤存活率增加4.3%但未达统计学显著。
研究设计与样本
- 多中心、多国、随机对照3期试验,在欧洲六国和加拿大的11个三级新生儿重症监护病房进行。
- 产前筛查1121名孕周<32周的孕妇,655名早产儿随机分组,主要结局分析607名:近红外光谱组304名,对照组303名。
- 干预为出生后最初15分钟即时过渡和复苏期间,在标准护理基础上加用脑氧饱和度监测及特定治疗指南(近红外光谱组) vs 单独标准护理(对照组)。
- 主要结局为无脑损伤存活复合终点,通过全因死亡和系列脑超声评估,脑损伤定义为矫正胎龄或出院前任何脑室内出血或囊性脑室周围白质软化或两者兼有。
主要发现
- 近红外光谱组252/304名(82.9%)无脑损伤存活,对照组238/303名(78.5%)无脑损伤存活(相对风险1.06,95%CI 0.98-1.14)。
- 近红外光谱组中位胎龄28.9周(四分位距26.9-30.6),对照组28.6周(26.6-30.6)。
- 死亡:近红外光谱组12名(4.0%) vs 对照组16名(5.3%),相对风险0.75(95%CI 0.33-1.70)。
- 两组脑组织氧饱和度相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether monitoring of cerebral tissue oxygen saturation using near infrared spectroscopy in addition to routine monitoring combined with defined treatment guidelines during immediate transition and resuscitation increases survival without cerebral injury of premature infants compared with standard care alone. DESIGN: Multicentre, multinational, randomised controlled phase 3 trial. SETTING: 11 tertiary neonatal intensive care units in six countries in Europe and in Canada. PARTICIPANTS: 1121 pregnant women (<32 weeks' gestation) were screened prenatally. The primary outcome was analysed in 607 of 655 randomised preterm neonates: 304 neonates in the near infrared spectroscopy group and 303 in the control group. INTERVENTION: Preterm neonates were randomly assigned to either standard care (control group) or standard care plus monitoring of cerebral oxygen saturation with a dedicated treatment guideline (near infrared spectroscopy group) during immediate transition (first 15 minutes after birth) and resuscitation. MAIN OUTCOME MEASURE: The primary outcome, assessed using all cause mortality and serial cerebral ultrasonography, was a composite of survival without cerebral injury. Cerebral injury was defined as any intraventricular haemorrhage or cystic periventricular leukomalacia, or both, at term equivalent age or before discharge. RESULTS: Cerebral tissue oxygen saturation was similar in both groups. 252 (82.9%) out of 304 neonates (median gestational age 28.9 (interquartile range 26.9-30.6) weeks) in the near infrared spectroscopy group survived without cerebral injury compared with 238 (78.5%) out of 303 neonates (28.6 (26.6-30.6) weeks) in the control group (relative risk 1.06, 95% confidence interval 0.98 to 1.14). 28 neonates died (near infrared spectroscopy group 12 (4.0%) v control group 16 (5.3%): relative risk 0.75 (0.33 to 1.70). CONCLUSION: Monitoring of cerebral tissue oxygen saturation in combination with dedicated interventions in preterm neonates (<32 weeks' gestation) during immediate transition and resuscitation after birth did not result in substantially higher survival without cerebral injury compared with standard care alone. Survival without cerebral injury increased by 4.3% but was not statistically significant. TRIAL REGISTRATION: ClinicalTrials.gov NCT03166722.
引用
- Pichler G, Goeral K, Hammerl M, et al. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial. BMJ. 2023. PMID: 36693654. doi:10.1136/bmj-2022-072313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。